Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Cardiology · Vasospastic Angina

Is Provocative Testing for Prinzmetal Angina Safe?

At a Glance

Provocative testing for Prinzmetal angina is generally safe when performed by an experienced cardiac catheterization team using small stepwise doses of medication, continuous monitoring, and nitroglycerin to reverse a temporary spasm. Serious complications are uncommon, but individual risks matter.

Yes, provocative testing for Prinzmetal angina (vasospastic angina) is generally considered safe when performed in a specialized cardiac catheterization laboratory by an experienced team. It is natural to feel terrified at the thought of a doctor intentionally triggering a heart spasm. However, the goal of this procedure is to safely induce a brief, temporary spasm to confirm the cause of your chest pain and then promptly reverse it [1][2].

While it is an invasive procedure with inherent risks, severe complications are uncommon, and strict safety protocols are in place [3]. It is important to know that this test is not for everyone, and your cardiologist will carefully weigh your individual risks and alternatives before recommending it [4].

Is This Test Right for You?

Provocative testing is often considered for patients who have persistent, unexplained chest pain but no significant blockages in their coronary arteries. In the medical world, this is sometimes seen in conditions like INOCA (Ischemia with Non-Obstructive Coronary Arteries) or MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries) [5][4].

  • Not universally required: This test is not automatically appropriate for everyone with INOCA or MINOCA. It is considered when doctors specifically suspect vasospastic angina and need a clear diagnosis to guide your care [4].
  • Guiding treatment: If the test confirms a spasm, it helps your doctor tailor treatments (like calcium-channel blockers or nitrates) to your specific condition. However, it does not guarantee that future spasms will be entirely prevented, and a negative test does not completely rule out other forms of microvascular disease [6].

How the Procedure is Kept Safe

During the test, your doctor will inject a medication—most commonly acetylcholine or ergonovine—to see how your coronary arteries react [7]. The medical team relies on several safeguards:

  • Step-by-Step Dosing: The provocation medicine is administered directly into the coronary artery in small, incremental doses [8].
  • Strict Stopping Criteria: The team continuously monitors your symptoms, your electrocardiogram (ECG), and live X-ray images of your coronary arteries. The test is stopped immediately if you experience your typical chest pain, if ischemic ECG changes occur, or if the X-ray shows severe temporary narrowing (spasm) of the artery [2][9].
  • Reversal Treatment: As soon as the test is stopped, doctors inject intracoronary nitroglycerin [2]. This acts as a rapid blood vessel relaxer to relieve the spasm [6]. Doctors then take another X-ray to visually confirm that the artery has opened and normal blood flow has been restored [10]. While nitroglycerin usually works quickly, on rare occasions the spasm may take longer to resolve and require additional emergency medications or support [11].
  • Continuous Monitoring and Support: Because medications like acetylcholine can temporarily slow the heart rate, some testing protocols include placing a temporary pacemaker wire as a backup [1]. The cath lab is also fully equipped with emergency medications, defibrillators, and advanced life support devices [12].

Understanding the Risks

Because this is an invasive catheterization procedure, it is not risk-free. Your individual risk depends on your overall health, heart function, and whether you have active ischemia or other medical conditions.

  • Spasm-Specific Risks: Large-scale research shows that serious complications are uncommon. A review of over 12,000 patients undergoing acetylcholine testing found that major complications (such as a heart attack, serious arrhythmias, or cardiogenic shock) occurred in about 0.5% of cases [3]. While several large studies report zero deaths [7][3], fatal complications are theoretically possible and cannot be completely ruled out.
  • Medication Differences: Studies have noted different complication rates depending on the medication used, the dose, and the specific patient population. For example, one large database study noted urgent rescue procedures or death in 0.9% of acetylcholine tests compared to 0.4% of ergonovine tests [13]. Your doctor will choose the most appropriate medication based on your health and their specific hospital protocol.
  • General Catheterization Risks: Like any heart catheterization, there are standard risks involved. These include bleeding or bruising at the access site (usually the wrist or groin), allergic reactions to contrast dye, kidney issues, and rarely, damage to the blood vessels or stroke.
  • Asthma Considerations: Acetylcholine can also affect the airways. If you have asthma, particularly if it is uncontrolled, it is critical to tell your doctor, as this may change whether acetylcholine is safe for you [14].

Before and After the Test

  • Before the test: Your doctor will give you specific instructions. Never stop taking your heart medications (like calcium-channel blockers or nitrates) unless your testing team explicitly instructs you to do so. You will be awake but lightly sedated, and the team will review your allergies, kidney function, and history of rhythm problems or asthma.
  • After the test: You will be monitored in a recovery area. Expect some soreness at the catheter access site. Your care team will tell you when you can resume normal activities and when to seek urgent emergency care (such as if you experience new, severe, or unrelieved chest pain).

Common questions in this guide

Is provocative testing for Prinzmetal angina generally safe?
Provocative testing is generally considered safe when it is performed in a specialized cardiac catheterization laboratory by an experienced team. It is invasive and not risk-free, so a cardiologist should weigh your health, the possible benefits, and alternatives before recommending it.
How do doctors stop a coronary spasm during the test?
The team gives small, stepwise doses of acetylcholine or ergonovine while watching your symptoms, ECG, and live X-ray images. They stop the test if typical chest pain, ECG changes, or severe artery narrowing occurs, then give intracoronary nitroglycerin to relax the artery and confirm that blood flow returns.
What serious complications can happen during provocative testing?
Serious complications are uncommon, but the test can cause a heart attack, a serious rhythm problem, or cardiogenic shock. In a review of more than 12,000 acetylcholine tests, major complications occurred in about 0.5%; catheterization also carries risks such as bleeding, contrast reactions, kidney problems, and rarely stroke.
What health conditions should I tell the testing team about?
Tell the team about asthma, especially if it is uncontrolled, as well as rhythm problems, kidney disease, allergies, and every medicine you take. Do not stop calcium-channel blockers, nitrates, or other heart medicines unless the testing team specifically tells you to.
Can the test results change my treatment?
A positive test can confirm that a temporary coronary artery spasm is contributing to your symptoms and may help your doctor choose calcium-channel blockers or nitrates. A negative result does not completely exclude other causes, including some forms of small-vessel heart disease.
Why might a temporary pacemaker be used during the test?
Some centers place a temporary pacemaker wire as a backup because acetylcholine can briefly slow the heart rate. Whether it is needed depends on the hospital’s protocol and your individual risk.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Prinzmetal angina.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many provocative tests for vasospastic angina does your team perform each year, and what is your emergency reversal protocol?
  2. 2.Which medication (acetylcholine or ergonovine) do you plan to use, and why is it the best choice for me?
  3. 3.Do you plan to use a temporary pacemaker during the procedure?
  4. 4.Will the results of this test significantly change the medications or treatment plan I am currently on?
  5. 5.Do any of my specific health conditions (such as asthma or a history of arrhythmias) increase my risk during this test?

References

References (14)
  1. 1

    Acetylcholine spasm provocation test by trans-radial artery and brachial vein approach.

    Sueda S, Fujimoto K, Sasaki Y, et al.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2019; (94(1)):38-44 doi:10.1002/ccd.27970.

    PMID: 30548131
  2. 2

    Feasibility of right coronary artery first ergonovine provocation test.

    Ham HS, Kim KH, Park J, et al.

    Acta cardiologica 2021; (76(1)):38-45 doi:10.1080/00015385.2019.1687966.

    PMID: 31707937
  3. 3

    Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.

    Takahashi T, Samuels BA, Li W, et al.

    Journal of the American College of Cardiology 2022; (79(24)):2367-2378 doi:10.1016/j.jacc.2022.03.385.

    PMID: 35710187
  4. 4

    Indications, contraindications, and usefulness of acetylcholine testing.

    Faiz F, Mehta S, Fleming S, Toleva O

    Cardiovascular revascularization medicine : including molecular interventions 2026; (88()):92-97 doi:10.1016/j.carrev.2026.02.012.

    PMID: 41792013
  5. 5

    Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries.

    Montone RA, Rinaldi R, Del Buono MG, et al.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2022; (18(8)):e666-e676 doi:10.4244/EIJ-D-21-00971.

    PMID: 35377315
  6. 6

    Acetylcholine Rechallenge: A First Step Toward Tailored Treatment in Patients With Coronary Artery Spasm.

    Seitz A, Feenstra R, Konst RE, et al.

    JACC. Cardiovascular interventions 2022; (15(1)):65-75 doi:10.1016/j.jcin.2021.10.003.

    PMID: 34991826
  7. 7

    Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm.

    Ciliberti G, Seshasai SRK, Ambrosio G, Kaski JC

    International journal of cardiology 2017; (244()):77-83 doi:10.1016/j.ijcard.2017.05.109.

    PMID: 28622945
  8. 8

    Intracoronary Acetylcholine Provocation Testing - Omission of the 20-µg Dose Is Feasible in Patients Without Coronary Artery Spasm in the Other Coronary Artery.

    Saito Y, Kitahara H, Shoji T, et al.

    Circulation journal : official journal of the Japanese Circulation Society 2016; (80(8)):1820-3 doi:10.1253/circj.CJ-16-0344.

    PMID: 27350015
  9. 9

    Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.

    Sueda S, Miyoshi T, Sasaki Y, et al.

    Coronary artery disease 2015; (26(6)):490-4 doi:10.1097/MCA.0000000000000267.

    PMID: 25974266
  10. 10

    Dynamic Resolution of Coronary Vasospasm: The Clasp-Knife Sign.

    Sezgin A, Kurklu HA, Avara A, et al.

    JACC. Case reports 2026; (31(35)):109120 doi:10.1016/j.jaccas.2026.109120.

    PMID: 42446449
  11. 11

    Spontaneous Multivessel Coronary Spasm During Diagnostic Coronary Angiography.

    Damera RR, Ijlal Khan M, Oliynyk V, Javaid A

    Texas Heart Institute journal 2022; (49(2)) doi:10.14503/THIJ-20-7357.

    PMID: 35377456
  12. 12

    Effects of radial artery spasm prophylaxis on intracoronary vasomotor responses during acetylcholine spasm provocation testing.

    Schäufele T, Nobre Menezes M, Schulte Steinberg B, et al.

    International journal of cardiology 2025; (419()):132703 doi:10.1016/j.ijcard.2024.132703.

    PMID: 39491593
  13. 13

    Serious cardiac complications in coronary spasm provocation tests using acetylcholine or ergonovine: analysis of 21 512 patients from the diagnosis procedure combination database in Japan.

    Isogai T, Yasunaga H, Matsui H, et al.

    Clinical cardiology 2015; (38(3)):171-7 doi:10.1002/clc.22369.

    PMID: 25693967
  14. 14

    Bronchial Asthma and Rest Angina: Is It Safe to Perform Acetylcholine Spasm Provocation Tests in These Patients?

    Sueda S

    Internal medicine (Tokyo, Japan) 2020; (59(24)):3117-3122 doi:10.2169/internalmedicine.5071-20.

    PMID: 32788543

This page is for informational purposes only and does not constitute medical advice. Your cardiologist should assess your health, medications, and alternatives before recommending provocative testing.